Global Cardiac Point of Care (PoC) Testing Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In March 2022, Mylab Discovery Solutions introduced an extensive array of routine diagnostic kits and devices, available in both conventional laboratory and point-of-care formats. This comprehensive launch encompasses devices and reagent kits tailored for Immunology, Biochemistry, and Haematology, enabling laboratories to conduct a wide range of routine tests. From liver panels to cardiac profiles, urine panels, hormone panels, and beyond, Mylab's offerings empower laboratories to efficiently perform various diagnostic procedures.

• In January 2022, at MEDLAB Middle East, Abbott, headquartered in Lake Forest, IL, USA, unveiled its portfolio of transformative diagnostic tools and medical devices designed for point-of-care testing. These innovative solutions are geared towards managing patients with COVID-19, diabetes, cardiovascular disease, and associated comorbidities. Abbott's showcase underscores its commitment to providing cutting-edge diagnostic capabilities that enable healthcare professionals to deliver timely and precise care, particularly in critical areas such as infectious diseases and chronic conditions.

The global cardiac point-of-care (PoC) testing devices market is experiencing significant growth and innovation driven by increasing incidences of cardiovascular diseases worldwide. These compact, portable devices offer rapid and accurate diagnostics, enabling healthcare providers to make timely treatment decisions, thereby improving patient outcomes. Factors such as the rising prevalence of lifestyle-related risk factors including obesity, diabetes, and hypertension, coupled with an aging population, are fueling the demand for cardiac PoC testing devices.

In addition to traditional cardiac biomarkers such as troponin and creatine kinase-MB (CK-MB), there is a growing trend towards the development of novel biomarkers and advanced technologies for improved diagnosis and risk stratification. This includes the integration of point-of-care ultrasound (POCUS) devices with cardiac biomarker testing, providing a more comprehensive assessment of cardiac function at the bedside. Moreover, technological advancements such as miniaturization, connectivity, and enhanced sensitivity are further driving market growth by facilitating remote monitoring and real-time data transmission for better patient management.

Geographically, North America dominates the global cardiac PoC testing devices market owing to the presence of well-established healthcare infrastructure, high healthcare expenditure, and early adoption of advanced diagnostic technologies. However, Asia-Pacific is expected to witness the fastest growth rate during the forecast period, fueled by increasing healthcare expenditure, rising awareness about preventive healthcare, and the growing burden of cardiovascular diseases in emerging economies such as China and India. Strategic collaborations, mergers, and acquisitions among key players are also shaping the competitive landscape of the market, with a focus on expanding product portfolios and geographic presence to capitalize on emerging opportunities. Overall, the cardiac PoC testing devices market is poised for continued growth, driven by technological innovation, increasing disease burden, and the need for efficient and cost-effective diagnostic solutions in healthcare settings globally.

Global Cardiac Point of Care (PoC) Testing Devices Segment Analysis

In this report, the Global Cardiac Point of Care (PoC) Testing Devices Market has been segmented by Product Type, End Users and Geography.

Global Cardiac Point of Care (PoC) Testing Devices Market, Segmentation by Product Type

The Global Cardiac Point of Care (PoC) Testing Devices Market has been segmented by Product Type into Cardiac Markers Test and Analyzers.

Cardiac markers tests are vital diagnostic tools used to assess the presence and severity of cardiac conditions. These tests detect specific biomarkers, such as troponin, creatine kinase-MB (CK-MB), and myoglobin, which are released into the bloodstream during heart-related events like myocardial infarction or heart failure. Rapid and accurate detection of these markers is crucial for timely diagnosis and intervention, improving patient outcomes.

Analyzers play a pivotal role in the cardiac PoC testing landscape by facilitating the measurement and analysis of cardiac biomarkers. These devices are designed to provide precise quantification of biomarker levels, enabling healthcare professionals to make informed decisions regarding patient management. Analyzers vary in complexity, ranging from compact handheld devices suitable for point-of-care settings to larger, laboratory-based systems capable of processing high volumes of samples.

Global Cardiac Point of Care (PoC) Testing Devices Market, Segmentation by End Users

The Global Cardiac Point of Care (PoC) Testing Devices Market has been segmented by End Users into Research Laboratories, Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories and Others.

Research Laboratories constitute a key end-user segment for cardiac PoC testing devices. These laboratories are often involved in cutting-edge research aimed at understanding cardiovascular diseases better and developing innovative diagnostic and therapeutic solutions. Cardiac PoC testing devices find extensive utility in such settings, enabling researchers to conduct rapid and accurate diagnostic tests on samples collected during their studies.

Hospitals represent another significant end-user segment for cardiac PoC testing devices. With the rising burden of cardiovascular diseases, hospitals increasingly rely on efficient diagnostic tools to streamline patient care processes. Cardiac PoC testing devices offer the advantage of delivering quick and reliable results, allowing healthcare professionals to make timely decisions regarding patient management and treatment.

Ambulatory Surgical Centers also form a notable end-user segment for cardiac PoC testing devices. These centers specialize in providing same-day surgical procedures and other medical services outside of traditional hospital settings. Cardiac PoC testing devices enable these centers to conduct pre-operative assessments, monitor patients during procedures, and assess post-operative cardiac function conveniently and swiftly.

Diagnostic Laboratories constitute another essential end-user segment for cardiac PoC testing devices. These laboratories are tasked with performing a wide range of diagnostic tests, including those related to cardiovascular health. The adoption of cardiac PoC testing devices in diagnostic laboratories helps enhance operational efficiency by reducing turnaround times for test results and facilitating prompt patient diagnosis and management.

Global Cardiac Point of Care (PoC) Testing Devices Market, Segmentation by Geography

In this report, the Global Cardiac Point of Care (PoC) Testing Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Cardiac Point of Care (PoC) Testing Devices Market Share (%), by Geographical Region, 2024

North America stands out as a leading market for cardiac PoC testing devices, driven by factors such as a well-established healthcare infrastructure, high adoption rates of innovative medical technologies, and a growing prevalence of cardiovascular diseases. The presence of key market players and extensive research and development activities further contribute to the region's dominance in the market.

Europe also holds a substantial share in the global cardiac PoC testing devices market, propelled by rising healthcare expenditure, increasing geriatric population, and supportive government initiatives aimed at improving cardiac care. Countries like Germany, the UK, and France are witnessing significant demand for these devices due to the high burden of cardiovascular diseases.

The Asia Pacific region is emerging as a lucrative market for cardiac PoC testing devices, fueled by rapid urbanization, improving healthcare infrastructure, and growing awareness about the importance of preventive healthcare measures. Countries such as China, India, and Japan are experiencing a surge in demand for these devices owing to the rising prevalence of lifestyle-related disorders and the increasing adoption of point-of-care diagnostics.

In the Middle East and Africa region, the market for cardiac PoC testing devices is witnessing steady growth, supported by initiatives aimed at enhancing healthcare access and infrastructure development. Despite challenges related to economic instability and limited healthcare resources in certain countries, there is a growing focus on addressing the burden of cardiovascular diseases through early detection and management.

Latin America also presents opportunities for market expansion, driven by increasing healthcare expenditure, rising awareness about cardiovascular health, and the presence of untapped markets. Countries like Brazil and Mexico are expected to contribute significantly to the region's market growth, supported by favorable government policies and investments in healthcare infrastructure.

This report provides an in depth analysis of various factors that impact the dynamics of Global Cardiac Point of Care (PoC) Testing Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunities Analysis

Drivers

• Rising Incidence of Cardiovascular Diseases
• Technological Advancements
• Growing Emphasis on Early Diagnosis

• Increasing Point-of-Care Testing Demand: The global cardiac point of care (PoC) testing devices market has been experiencing significant growth, primarily driven by the increasing demand for point-of-care testing (POCT). POCT offers rapid and convenient diagnostic solutions, enabling healthcare providers to obtain immediate results without the need for laboratory infrastructure or specialized personnel. In the field of cardiac care, PoC testing devices play a crucial role in the early detection, monitoring, and management of cardiovascular conditions such as myocardial infarction, heart failure, and arrhythmias.

  One of the key factors fueling the demand for cardiac PoC testing devices is the rising prevalence of cardiovascular diseases worldwide. With cardiovascular disorders being a leading cause of morbidity and mortality globally, there is a growing emphasis on preventive healthcare and early disease detection. Cardiac PoC testing devices enable timely diagnosis and intervention, facilitating better patient outcomes and reducing healthcare costs associated with prolonged hospital stays and complications.

  Technological advancements in PoC testing devices have led to the development of more accurate, reliable, and user-friendly platforms. Miniaturization, automation, and integration of multiple testing parameters have enhanced the efficiency and performance of these devices, making them indispensable tools in both clinical and non-clinical settings. Furthermore, the COVID-19 pandemic has underscored the importance of rapid diagnostic testing, spurring further innovation and investment in PoC testing technologies across various healthcare domains, including cardiology.

Restraints

• Regulatory Challenges
• High Cost of Devices
• Limited Reimbursement Policies

• Technical Challenges: The global cardiac point-of-care (PoC) testing devices market has seen remarkable growth in recent years, driven by the increasing prevalence of cardiovascular diseases worldwide and the demand for rapid and accurate diagnostic solutions. However, alongside this growth, the market faces several technical challenges that need to be addressed for further advancement.

  Ensuring the accuracy and reliability of PoC testing devices remains a significant concern. While these devices offer rapid results, maintaining high levels of precision comparable to laboratory-based tests is essential. Factors such as sample integrity, environmental conditions, and variations in testing methodologies can affect the accuracy of results, posing a challenge for manufacturers to develop robust and reliable devices.

  The complexity of cardiac biomarkers presents another technical hurdle. Cardiac biomarkers, such as troponin and B-type natriuretic peptide (BNP), play a crucial role in diagnosing and monitoring cardiovascular diseases. However, detecting these biomarkers accurately in point-of-care settings requires sophisticated technologies capable of handling low concentrations of analytes in diverse sample types, such as whole blood or serum.

Opportunities

• Expansion in Emerging Markets
• Strategic Partnerships and Collaborations
• Customization and Personalization

• Integration with Digital Health Solutions: The global cardiac Point of Care (PoC) testing devices market is witnessing a significant surge in integration with digital health solutions, marking a pivotal shift in how cardiovascular health is managed and monitored. As technology continues to evolve, the convergence of PoC testing devices with digital platforms enables seamless data collection, analysis, and transmission, empowering both patients and healthcare providers with real-time insights. This integration not only enhances the efficiency of cardiac care delivery but also fosters proactive management strategies, ultimately improving patient outcomes.

  One key driver behind this trend is the growing demand for remote monitoring and telemedicine solutions, especially in the wake of the COVID-19 pandemic. Patients are increasingly seeking convenient ways to monitor their cardiac health from the comfort of their homes, while healthcare providers are exploring innovative approaches to deliver timely interventions and optimize resource utilization. Digital health solutions offer a bridge between traditional healthcare settings and remote patient care, enabling continuous monitoring and early detection of cardiac abnormalities through PoC testing devices.

  The advent of wearable technology and mobile health applications has further fueled the integration of cardiac PoC testing devices with digital platforms. These devices allow for continuous monitoring of vital signs, such as heart rate and rhythm, providing a comprehensive picture of an individual's cardiovascular health beyond the confines of a clinical setting. By harnessing the power of data analytics and artificial intelligence, digital health solutions can analyze vast amounts of physiological data in real-time, alerting both patients and healthcare providers to potential cardiac issues promptly.

Key players in Global Cardiac Point of Care (PoC) Testing Devices Market include:

• Abbott Laboratories
• ACON Laboratories Inc
• Alfa Scientific Designs Inc
• American Screening Corporation Inc
• Beckman Coulter Inc
• Bio-Rad Laboratories Inc
• F. Hoffmann-La Roche Ltd
• Nano-Ditech Corporation
• Nova Biomedical Corporation
• Siemens Healthineers AG

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis